Detailed Information
Cited 5 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Safety and efficacy of durvalumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from the phase 2 study 22 (NCT02519348)
- Authors
- Lim, HY[Lim, Ho Yeong]; Heo, J[Heo, Jeong]; Kim, TY[Kim, Tae-You]; Tai, WMD[Tai, Wai Meng David]; Kang, YK[Kang, Yoon-Koo]; Lau, G[Lau, George]; Kudo, M[Kudo, Masatoshi]; Tak, WY[Tak, Won Young]; Watras, M[Watras, Magdalena]; Ali, SK[Ali, Sajid K.]; Negro, A[Negro, Alejandra]; Abou-Alfa, GK[Abou-Alfa, Ghassan K.]; Kelley, RK[Kelley, Robin Kate]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.